nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—PTGS2—adrenal gland cancer	0.924	1	CbGaD
Tolmetin—TDO2—pituitary gland—adrenal gland cancer	0.00273	0.195	CbGeAlD
Tolmetin—TDO2—adrenal gland—adrenal gland cancer	0.00244	0.174	CbGeAlD
Tolmetin—CXCL8—adrenal cortex—adrenal gland cancer	0.00186	0.133	CbGeAlD
Tolmetin—Ketorolac—PTGS2—adrenal gland cancer	0.00185	0.191	CrCbGaD
Tolmetin—Bromfenac—PTGS2—adrenal gland cancer	0.00177	0.184	CrCbGaD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—PRKACA—adrenal gland cancer	0.00177	0.034	CbGpPWpGaD
Tolmetin—Lumiracoxib—PTGS2—adrenal gland cancer	0.00151	0.156	CrCbGaD
Tolmetin—CXCL8—pituitary gland—adrenal gland cancer	0.0015	0.107	CbGeAlD
Tolmetin—CXCL8—Syndecan-3-mediated signaling events—POMC—adrenal gland cancer	0.00149	0.0285	CbGpPWpGaD
Tolmetin—CXCL8—IL-3 Signaling Pathway—PRKACA—adrenal gland cancer	0.00138	0.0265	CbGpPWpGaD
Tolmetin—Fenbufen—PTGS2—adrenal gland cancer	0.00137	0.142	CrCbGaD
Tolmetin—CXCL8—adrenal gland—adrenal gland cancer	0.00134	0.0959	CbGeAlD
Tolmetin—CXCL8—Overview of nanoparticle effects—PTGS2—adrenal gland cancer	0.00129	0.0247	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MED12—adrenal gland cancer	0.00128	0.0246	CbGpPWpGaD
Tolmetin—Suprofen—PTGS2—adrenal gland cancer	0.00114	0.118	CrCbGaD
Tolmetin—CXCL8—Bladder Cancer—BRAF—adrenal gland cancer	0.00108	0.0206	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—RB1—adrenal gland cancer	0.00106	0.0203	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—CDKN2A—adrenal gland cancer	0.000929	0.0178	CbGpPWpGaD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—PRKACA—adrenal gland cancer	0.000922	0.0177	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—PRKACA—adrenal gland cancer	0.000916	0.0176	CbGpPWpGaD
Tolmetin—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—adrenal gland cancer	0.000905	0.0174	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—SPARC—adrenal gland cancer	0.000891	0.0171	CbGpPWpGaD
Tolmetin—MPO—pituitary gland—adrenal gland cancer	0.000879	0.0628	CbGeAlD
Tolmetin—CXCL8—Syndecan-3-mediated signaling events—EGFR—adrenal gland cancer	0.000841	0.0161	CbGpPWpGaD
Tolmetin—CXCL8—IL-3 Signaling Pathway—BAD—adrenal gland cancer	0.000819	0.0157	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.000819	0.0157	CbGpPWpGaD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—adrenal gland cancer	0.000806	0.0155	CbGpPWpGaD
Tolmetin—MPO—adrenal gland—adrenal gland cancer	0.000785	0.0561	CbGeAlD
Tolmetin—CXCL8—Allograft Rejection—ABCB1—adrenal gland cancer	0.000751	0.0144	CbGpPWpGaD
Tolmetin—Indomethacin—PTGS2—adrenal gland cancer	0.000727	0.0752	CrCbGaD
Tolmetin—PTGS1—Overview of nanoparticle effects—PTGS2—adrenal gland cancer	0.000709	0.0136	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—GNAS—adrenal gland cancer	0.000677	0.013	CbGpPWpGaD
Tolmetin—Aminohippurate—ABCB1—adrenal gland cancer	0.000673	0.0697	CrCbGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—adrenal gland cancer	0.000636	0.0122	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—SDHB—adrenal gland cancer	0.000635	0.0122	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—RB1—adrenal gland cancer	0.000632	0.0121	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—GNRHR—adrenal gland cancer	0.000624	0.012	CbGpPWpGaD
Tolmetin—Indomethacin—ABCB1—adrenal gland cancer	0.000618	0.064	CrCbGaD
Tolmetin—CXCL8—Bladder Cancer—EGFR—adrenal gland cancer	0.000616	0.0118	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IGF1R—adrenal gland cancer	0.000594	0.0114	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—adrenal gland cancer	0.000593	0.0114	CbGpPWpGaD
Tolmetin—PTGS1—Eicosanoid Synthesis—PTGS2—adrenal gland cancer	0.000588	0.0113	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—CDC42—adrenal gland cancer	0.000581	0.0111	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—CDKN2A—adrenal gland cancer	0.000564	0.0108	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.000548	0.0105	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—PTGS2—adrenal gland cancer	0.000528	0.0101	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—TP53—adrenal gland cancer	0.000517	0.00992	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.000508	0.00975	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—POMC—adrenal gland cancer	0.0005	0.00959	CbGpPWpGaD
Tolmetin—PTGS2—adrenal cortex—adrenal gland cancer	0.000493	0.0352	CbGeAlD
Tolmetin—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—adrenal gland cancer	0.000492	0.00944	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.000491	0.00941	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—CDKN2A—adrenal gland cancer	0.000484	0.00929	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—POMC—adrenal gland cancer	0.000456	0.00875	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—BRAF—adrenal gland cancer	0.00045	0.00864	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.000437	0.00839	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—adrenal gland cancer	0.000435	0.00835	CbGpPWpGaD
Tolmetin—PTGS1—cardiac atrium—adrenal gland cancer	0.000427	0.0305	CbGeAlD
Tolmetin—PTGS1—pituitary gland—adrenal gland cancer	0.000417	0.0298	CbGeAlD
Tolmetin—TDO2—Metabolism—SDHD—adrenal gland cancer	0.000409	0.00784	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—RRM1—adrenal gland cancer	0.000409	0.00784	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—BRAF—adrenal gland cancer	0.000405	0.00777	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—CTNNB1—adrenal gland cancer	0.000405	0.00777	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000404	0.00774	CbGpPWpGaD
Tolmetin—PTGS2—pituitary gland—adrenal gland cancer	0.000399	0.0285	CbGeAlD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—RB1—adrenal gland cancer	0.000398	0.00764	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—TP53—adrenal gland cancer	0.000381	0.00731	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000375	0.0072	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000374	0.00717	CbGpPWpGaD
Tolmetin—PTGS1—adrenal gland—adrenal gland cancer	0.000373	0.0266	CbGeAlD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—adrenal gland cancer	0.000364	0.00698	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—RB1—adrenal gland cancer	0.000363	0.00696	CbGpPWpGaD
Tolmetin—PTGS2—adrenal gland—adrenal gland cancer	0.000356	0.0254	CbGeAlD
Tolmetin—CXCL8—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000352	0.00676	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—CDKN2A—adrenal gland cancer	0.00035	0.00672	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDKN2A—adrenal gland cancer	0.00035	0.00672	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—EGFR—adrenal gland cancer	0.000345	0.00661	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.000338	0.00648	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—TSHR—adrenal gland cancer	0.000333	0.00639	CbGpPWpGaD
Tolmetin—PTGS1—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000327	0.00627	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—CTNNB1—adrenal gland cancer	0.000326	0.00625	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00032	0.00614	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00032	0.00614	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—MED12—adrenal gland cancer	0.000305	0.00585	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—PTGS2—adrenal gland cancer	0.000298	0.00572	CbGpPWpGaD
Tolmetin—PTGS1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000287	0.00551	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—REN—adrenal gland cancer	0.000275	0.00529	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—TP53—adrenal gland cancer	0.000269	0.00517	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.000255	0.0049	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CDC42—adrenal gland cancer	0.000255	0.00488	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—RB1—adrenal gland cancer	0.000252	0.00484	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—TP53—adrenal gland cancer	0.000237	0.00455	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000232	0.00445	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PRKACA—adrenal gland cancer	0.000222	0.00427	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CDKN2A—adrenal gland cancer	0.000222	0.00425	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000215	0.00413	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000213	0.00409	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—EGFR—adrenal gland cancer	0.000211	0.00405	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000211	0.00405	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.000208	0.00399	CbGpPWpGaD
Tolmetin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—adrenal gland cancer	0.000206	0.00394	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.000197	0.00377	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TP53—adrenal gland cancer	0.000195	0.00374	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—GNAS—adrenal gland cancer	0.000194	0.00372	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000192	0.00368	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—RB1—adrenal gland cancer	0.00019	0.00365	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GNRHR—adrenal gland cancer	0.000189	0.00363	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000188	0.00361	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CDKN2A—adrenal gland cancer	0.000183	0.00352	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—GNAS—adrenal gland cancer	0.00018	0.00346	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TP53—adrenal gland cancer	0.000177	0.0034	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—ABCB1—adrenal gland cancer	0.000177	0.00339	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000176	0.00337	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000171	0.00329	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—TSHR—adrenal gland cancer	0.000171	0.00328	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN2A—adrenal gland cancer	0.000167	0.00321	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000165	0.00317	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.000162	0.00311	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—RB1—adrenal gland cancer	0.000159	0.00305	CbGpPWpGaD
Tolmetin—PTGS1—Biological oxidations—POMC—adrenal gland cancer	0.000153	0.00293	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000147	0.00282	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—IGF2—adrenal gland cancer	0.000137	0.00264	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SDHB—adrenal gland cancer	0.000136	0.00262	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—POMC—adrenal gland cancer	0.00013	0.0025	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000126	0.00242	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—TP53—adrenal gland cancer	0.000123	0.00237	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000123	0.00235	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—POMC—adrenal gland cancer	0.000121	0.00233	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000121	0.00232	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000117	0.00224	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000115	0.0022	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GNRH1—adrenal gland cancer	0.000113	0.00217	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SH3KBP1—adrenal gland cancer	0.00011	0.00211	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000109	0.0021	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SDHB—adrenal gland cancer	0.000108	0.00208	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000107	0.00206	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CDC42—adrenal gland cancer	0.000104	0.002	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SPRY2—adrenal gland cancer	0.000104	0.00199	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ZNRF3—adrenal gland cancer	0.000103	0.00198	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000102	0.00196	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TSHR—adrenal gland cancer	0.000101	0.00194	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.0001	0.00192	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—GNAS—adrenal gland cancer	9.94e-05	0.00191	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PTGS2—adrenal gland cancer	9.68e-05	0.00186	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MEN1—adrenal gland cancer	9.49e-05	0.00182	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—TP53—adrenal gland cancer	9.32e-05	0.00179	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—EGFR—adrenal gland cancer	9.26e-05	0.00178	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—POMC—adrenal gland cancer	9.17e-05	0.00176	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—RRM1—adrenal gland cancer	8.79e-05	0.00169	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SDHD—adrenal gland cancer	8.79e-05	0.00169	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	8.52e-05	0.00164	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	7.95e-05	0.00153	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TP53—adrenal gland cancer	7.77e-05	0.00149	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—POMC—adrenal gland cancer	7.37e-05	0.00141	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PRKACA—adrenal gland cancer	7.25e-05	0.00139	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—RRM1—adrenal gland cancer	6.98e-05	0.00134	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SDHD—adrenal gland cancer	6.98e-05	0.00134	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—POMC—adrenal gland cancer	6.69e-05	0.00128	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—MED12—adrenal gland cancer	6.55e-05	0.00126	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—CTNNB1—adrenal gland cancer	6.55e-05	0.00126	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SPRY2—adrenal gland cancer	6.48e-05	0.00124	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	6.3e-05	0.00121	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDC42—adrenal gland cancer	6.15e-05	0.00118	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MEN1—adrenal gland cancer	5.94e-05	0.00114	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IGF2—adrenal gland cancer	5.92e-05	0.00114	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GNAS—adrenal gland cancer	5.87e-05	0.00113	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	5.86e-05	0.00112	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IGF1R—adrenal gland cancer	5.73e-05	0.0011	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	5.29e-05	0.00101	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—MED12—adrenal gland cancer	5.2e-05	0.000998	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TERT—adrenal gland cancer	4.93e-05	0.000946	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PRKACA—adrenal gland cancer	4.78e-05	0.000917	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	4.67e-05	0.000897	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	4.65e-05	0.000892	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PRKACA—adrenal gland cancer	4.53e-05	0.000869	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—BAD—adrenal gland cancer	4.29e-05	0.000823	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—POMC—adrenal gland cancer	3.95e-05	0.000759	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—BRAF—adrenal gland cancer	3.9e-05	0.000749	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GNAS—adrenal gland cancer	3.88e-05	0.000743	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDC42—adrenal gland cancer	3.84e-05	0.000738	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ABCB1—adrenal gland cancer	3.8e-05	0.00073	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PRKACA—adrenal gland cancer	3.8e-05	0.000728	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—EGFR—adrenal gland cancer	3.78e-05	0.000726	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TERT—adrenal gland cancer	3.08e-05	0.000592	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GNAS—adrenal gland cancer	3.08e-05	0.00059	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ABCB1—adrenal gland cancer	3.02e-05	0.000579	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CTNNB1—adrenal gland cancer	2.82e-05	0.000541	CbGpPWpGaD
Tolmetin—PTGS2—Disease—BAD—adrenal gland cancer	2.68e-05	0.000515	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—POMC—adrenal gland cancer	2.61e-05	0.000501	CbGpPWpGaD
Tolmetin—PTGS2—Disease—BRAF—adrenal gland cancer	2.44e-05	0.000469	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EGFR—adrenal gland cancer	2.24e-05	0.000429	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTGS2—adrenal gland cancer	2.08e-05	0.000399	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—POMC—adrenal gland cancer	2.07e-05	0.000397	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TP53—adrenal gland cancer	1.88e-05	0.00036	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CTNNB1—adrenal gland cancer	1.77e-05	0.000339	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EGFR—adrenal gland cancer	1.4e-05	0.000268	CbGpPWpGaD
